Cancer letters

Cancer Lett · ISSN (print) 0304-3835 · 13 papers in corpus
2024
doi:10.1016/j.canlet.2024.217357 ·PMID:39615646

Ovarian cancer (OC) accounts for the highest mortality rates among all gynecologic malignancies. The high mortality of OC is often associated with delayed detection, prolonged latency, enhanced metastatic potential, acquired drug resistance…

2021
doi:10.1016/j.canlet.2021.04.011 ·PMID:33895262

Immune checkpoint blockade has shown unprecedented and durable clinical response in a wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory checkpoint protein that is highly expressed in tumor-infiltrating …

other 2020
doi:10.1016/j.canlet.2019.10.019 ·PMID:31629931

Selective estrogen receptor modulators (SERMs) are a class of structurally diverse compounds, which have been extensively used to treat hormone-responsive cancers due to their unique partially agonistic and antagonistic properties toward es…

other 2017
doi:10.1016/j.canlet.2017.04.040 ·PMID:28483516

The chromatin remodeler AT-Rich Interactive Domain 1A (ARID1A) is frequently mutated in ovarian clear cell carcinoma (OCCC) and endometriosis precursor lesions. Here, we show that knocking down ARID1A in an immortalized endometriosis cell l…

2017
doi:10.1016/j.canlet.2017.05.011 ·PMID:28549791

Gynecological cancers (GCs) are often diagnosed at advanced stages, limiting the efficacy of available therapeutic options. Thus, there remains an urgent and unmet need for innovative research for the efficient clinical management of GC pat…

2015
doi:10.1016/j.canlet.2014.04.018 ·PMID:24784887

There is currently accumulating evidence that endogenous estrogens play a critical role in the development of breast cancer. Estrogens and their metabolites have been studied in both pre- and postmenopausal women with more consistent result…

2015
doi:10.1016/j.canlet.2014.09.036 ·PMID:25304370

Endometrial cancer is the leading gynecologic cancer in women in the United States with 52,630 women predicted to be diagnosed with the disease in 2014. The objective of this study was to determine if progesterone (P4) receptor membrane com…

2013
doi:10.1016/j.canlet.2013.06.026 ·PMID:23851185

The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor mediates many biological processes. Herein, we investigated if 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE, an endogenous AhR ligand) r…

2013
doi:10.1016/j.canlet.2013.02.043 ·PMID:23454583

MicroRNAs (miRNAs) are endogenous, non-coding RNA transcripts that regulate gene expression. Here, we report 175 putative novel miRNAs identified in uterine cancers profiled by Next Generation Sequencing. Our data indicate that one of these…

2012
doi:10.1016/j.canlet.2012.02.002 ·PMID:22334034

Cancer stem cells are rare chemotherapy resistant cells within a tumor which can serve to populate the bulk of a tumor with more differentiated daughter cells and potentially contribute to recurrent disease. Ovarian cancer is a disease for …

review 2011
doi:10.1016/j.canlet.2011.06.039 ·PMID:21802200

Although it is well known that ovarian endometriosis occasionally gives rise to ovarian cancers with specific histology such as endometrioid and clear cell carcinomas, its etiology is not fully understood. We have shown that a stressful mic…

2010
doi:10.1016/j.canlet.2010.03.013 ·PMID:20381233

The HE4 protein is overexpressed in ovarian carcinomas and can be detected in serum by an ELISA with sensitivity similar to CA125 and higher specificity for malignant disease. We now demonstrate that HE4 can also be detected in the urine at…

article 1987
doi:10.1016/0304-3835(87)90001-2 ·PMID:3815324

Mice exposed prenatally to diethylstilbestrol (DES) were ovariectomized at 5-10 weeks of age, or at 15 months of age. They were maintained to old age and studied for incidence of DES-related pathologic changes. Uterine metaplasia and adenom…